News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
743,944 Results
Type
Article (42626)
Company Profile (308)
Press Release (700995)
Multimedia
Podcasts (99)
Webinars (20)
Section
Business (207742)
Career Advice (2076)
Deals (35933)
Drug Delivery (135)
Drug Development (82453)
Employer Resources (175)
FDA (16574)
Job Trends (15214)
News (351211)
Policy (33060)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2634)
Accelerated approval (53)
Adcomms (27)
Allergies (180)
Alliances (50510)
ALS (222)
Alzheimer's disease (1826)
Antibody-drug conjugate (ADC) (495)
Approvals (16999)
Artificial intelligence (705)
Autoimmune disease (322)
Automation (59)
Bankruptcy (365)
Best Places to Work (11744)
BIOSECURE Act (22)
Biosimilars (228)
Biotechnology (207)
Bladder cancer (200)
Brain cancer (73)
Breast cancer (788)
Cancer (6151)
Cardiovascular disease (486)
Career advice (1767)
Career pathing (44)
CAR-T (351)
CDC (58)
Celiac Disease (3)
Cell therapy (954)
Cervical cancer (51)
Clinical research (71909)
Collaboration (2162)
Company closure (5)
Compensation (1460)
Complete response letters (82)
COVID-19 (2777)
CRISPR (115)
C-suite (1200)
Cystic fibrosis (154)
Data (8406)
Decentralized trials (3)
Denatured (28)
Depression (170)
Dermatology (93)
Diabetes (618)
Diagnostics (7031)
Digital health (59)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (340)
Drug pricing (203)
Drug shortages (31)
Duchenne muscular dystrophy (293)
Earnings (92755)
Editorial (68)
Employer branding (21)
Employer resources (154)
Events (123377)
Executive appointments (1119)
FDA (20448)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1803)
Gene editing (245)
Generative AI (63)
Gene therapy (755)
GLP-1 (1071)
Government (4769)
Grass and pollen (6)
Guidances (414)
Healthcare (19240)
HIV (83)
Huntington's disease (58)
IgA nephropathy (109)
Immunology and inflammation (292)
Immuno-oncology (102)
Indications (201)
Infectious disease (3133)
Inflammatory bowel disease (219)
Inflation Reduction Act (14)
Influenza (138)
Intellectual property (307)
Interviews (325)
IPO (16790)
IRA (50)
Job creations (3770)
Job search strategy (1466)
JPM (58)
Kidney cancer (20)
Labor market (107)
Layoffs (571)
Leadership (42)
Legal (8033)
Liver cancer (102)
Longevity (35)
Lung cancer (819)
Lymphoma (452)
Machine learning (62)
Management (59)
Manufacturing (1106)
MASH (200)
Medical device (13982)
Medtech (14124)
Mergers & acquisitions (20419)
Metabolic disorders (1570)
mRNA (219)
Multiple sclerosis (194)
NASH (17)
Neurodegenerative disease (442)
Neuropsychiatric disorders (107)
Neuroscience (3413)
Neurotech (1)
NextGen: Class of 2026 (6600)
Non-profit (4569)
Now hiring (79)
Obesity (728)
Opinion (303)
Ovarian cancer (233)
Pain (259)
Pancreatic cancer (333)
Parkinson's disease (385)
Partnered (33)
Patents (616)
Patient recruitment (707)
Peanut (65)
People (60854)
Pharmaceutical (62)
Pharmacy benefit managers (33)
Phase 1 (22509)
Phase 2 (31721)
Phase 3 (23450)
Pipeline (9342)
Policy (327)
Postmarket research (2580)
Preclinical (9595)
Press Release (71)
Prostate cancer (325)
Psychedelics (54)
Radiopharmaceuticals (339)
Rare diseases (1121)
Real estate (6146)
Recruiting (72)
Regulatory (25811)
Reports (57)
Research institute (2453)
Resumes & cover letters (360)
Rett syndrome (39)
RNA editing (23)
RSV (88)
Schizophrenia (180)
Series A (306)
Series B (224)
Service/supplier (11)
Sickle cell disease (122)
Special edition (25)
Spinal muscular atrophy (167)
Sponsored (48)
Startups (3755)
State (2)
Stomach cancer (18)
Supply chain (130)
Tariffs (90)
The Weekly (69)
Vaccines (1126)
Venture capital (117)
Weight loss (467)
Women's health (131)
Worklife (20)
Date
Last 7 days (736)
Last 30 days (3067)
Last 365 days (30619)
2026 (14587)
2025 (30618)
2024 (35633)
2023 (40434)
2022 (51650)
2021 (56117)
2020 (54492)
2019 (46938)
2018 (35384)
2017 (32541)
2016 (32073)
2015 (38047)
2014 (31839)
2013 (26866)
2012 (29191)
2011 (29867)
2010 (27971)
Location
Africa (772)
Alabama (93)
Alaska (7)
Arizona (371)
Arkansas (15)
Asia (40797)
Australia (6818)
California (13817)
Canada (3865)
China (1446)
Colorado (584)
Connecticut (604)
Delaware (424)
Europe (89032)
Florida (2047)
Georgia (442)
Hawaii (3)
Idaho (63)
Illinois (1133)
India (93)
Indiana (620)
Iowa (24)
Japan (567)
Kansas (136)
Kentucky (51)
Louisiana (44)
Maine (76)
Maryland (1641)
Massachusetts (9909)
Michigan (372)
Minnesota (742)
Mississippi (6)
Missouri (146)
Montana (36)
Nebraska (29)
Nevada (145)
New Hampshire (85)
New Jersey (3609)
New Mexico (31)
New York (3619)
North Carolina (1763)
North Dakota (10)
Northern California (6966)
Ohio (409)
Oklahoma (23)
Oregon (41)
Pennsylvania (2758)
Puerto Rico (29)
Rhode Island (51)
South America (1154)
South Carolina (86)
South Dakota (2)
Southern California (5450)
Tennessee (217)
Texas (2206)
United States (48729)
Utah (413)
Vermont (1)
Virginia (333)
Washington D.C. (81)
Washington State (1117)
West Virginia (4)
Wisconsin (131)
Wyoming (2)
743,944 Results for "phoenix biotechnology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
May 5, 2026
·
8 min read
Press Releases
Phoenix Children’s Names Chris Koch to its Board of Directors
May 27, 2026
·
3 min read
Press Releases
Picard Medical / SynCardia COO to Deliver Keynote at Venture Café Phoenix During Arizona Tech Week
April 2, 2026
·
4 min read
Press Releases
Tris Pharma to Showcase Encore Phase 3 Data Supporting Continued Progress in Acute Pain Treatment at ASRA 2026 Meeting in Phoenix
April 8, 2026
·
6 min read
Press Releases
University of Phoenix appoints Sheila Babendir as Dean of the College of Social and Behavioral Sciences
January 21, 2026
·
3 min read
Press Releases
Phoenix Children’s Research Institute Secures Three Prestigious National Institutes of Health (NIH) Grants
December 19, 2025
·
5 min read
Press Releases
Sana Biotechnology to Present at June 2026 Investor Conferences
May 27, 2026
·
3 min read
Press Releases
Curatis Expands Distribution Business With Phoenix Labs with up to CHF 5m Additional Annual Revenues
September 5, 2025
·
2 min read
Press Releases
MAIA Biotechnology Announces Open Market Purchases by CEO and Director
June 3, 2026
·
4 min read
Biotech Bay
Phoenix Biotech Acquisition Corp. and CERo Therapeutics, Inc. Announce Close of Business Combination
Phoenix Biotech Acquisition Corp. and CERo Therapeutics, Inc., an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms announced that their previously announced business combination has closed, resulting in CERo becoming a publicly-traded company.
February 14, 2024
·
2 min read
1 of 74,395
Next
